Ticker Scorecard - FATE Basics Company: Fate Therapeutics, Inc. IPO Date: October 1, 2013 Sector: Healthcare Industry: Biotech Market Cap: $189.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.60 | 3.45% Avg Daily Range (30 D): $0.08 | 4.32% Avg Daily Range (90 D): $0.10 | 4.12% Institutional Daily Volume Avg Daily Volume: .82M Avg Daily Volume (30 D): 2.74M Avg Daily Volume (90 D): 2.21M Trade Size Avg Trade Size (Sh.): 104 Avg Trade Size (Sh.) (30 D): 273 Avg Trade Size (Sh.) (90 D): 200 Institutional Trades Total Inst.Trades: 3,458 Avg Inst. Trade: $2.74M Avg Inst. Trade (30 D): $1.44M Avg Inst. Trade (90 D): $1.37M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.84M Avg Closing Trade (30 D): $2.3M Avg Closing Trade (90 D): $1.46M Avg Closing Volume: 204.17K     News Nov 29, 2024 @ 6:05 PM Fate Therapeutics Announces Leadership Transition Source: N/A Nov 9, 2024 @ 6:30 PM Fate Therapeutics Highlights Cancer-selective, HER... Source: N/A Aug 6, 2024 @ 12:45 PM Harmony Biosciences Holdings, Inc. (HRMY) Surpasse... Source: Zacks.Com Jun 4, 2024 @ 8:01 PM Fate Therapeutics Reports New Employee Inducement ... Source: Fate Therapeutics, Inc. May 29, 2024 @ 8:01 PM Fate Therapeutics to Present at 2024 Jefferies Glo... Source: Fate Therapeutics, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.65 $-.4 $-.33 Diluted EPS $-1.65 $-.4 $-.33 Revenue $ 13.45M $ 3.07M $ 6.77M Gross Profit $ $ $ Net Income / Loss $ -178.23M $ -47.68M $ -38.43M Operating Income / Loss $ -196.6M $ -52.38M $ -45.08M Cost of Revenue $ $ $ Net Cash Flow $ -.38M $ -3.96M $ -84.41M PE Ratio